CD8A and breast carcinoma: Based on these results, the major challenge for augmenting the success of anti-tumor immunity and immunotherapy against breast cancer is to develop effective strategies to increase CD8+ T cells and keep the optimal balance of CD4/CD8 in the tumor microenvironment.